ENTRY       D11845                      Drug
NAME        Tidutamab (USAN/INN)
FORMULA     C5633H8660N1504O1740S38
EXACT_MASS  126430.4782
MOL_WEIGHT  126508.5363
SEQUENCE    (A chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS DYGMAWFRQA PGKGLEWVSF ISNLGYSIYY
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARAP YDYDSFDPMD YWGQGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSDTKVDKKV EPKSCDKTHT CPPCPAPPVA
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV KHEDPEVKFN WYVDGVEVHN AKTKPREEEY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
            EMTKNQVSLT CDVSGFYPSD IAVEWESDGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WEQGDVFSCS VMHEALHNHY TQKSLSLSPG K
            (B chain)
            DIVMTQSPDS LAVSLGERAT INCKSSQSLL NSRNRKNYLA WYQQKPDQSP KLLIYWASTR
            ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCKQSYYL WTFGGGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (C chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS TYAMNWVRQA PGKGLEWVGR IRSKYNNYAT
            YYADSVKGRF TISRDDSKNT LYLQMNSLRA EDTAVYYCVR HGNFGDSYVS WFAYWGQGTL
            VTVSSGKPGS GKPGSGKPGS GKPGSQAVVT QEPSLTVSPG GTVTLTCGSS TGAVTTSNYA
            NWVQQKPGKS PRGLIGGTNK RAPGVPARFS GSLLGGKAAL TISGAQPEDE ADYYCALWYS
            NHWVFGGGTK LTVLEPKSSD KTHTCPPCPA PPVAGPSVFL FPPKPKDTLM ISRTPEVTCV
            VVDVKHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK
            VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREQMTKNQ VKLTCLVKGF YPSDIAVEWE
            SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS
            LSPGK
            (Disulfide bridge: A22-A96, A149-A205, A225-B219, A231-C265, A234-C268, A265-A325, A371-A429, B23-B94, B139-B199, C22-C98, C167-C235, C299-C359, C405-C463)
  TYPE      Peptide
EFFICACY    Antineoplastic, Immunomodulator, Anti-somatostatin receptor 2 antibody
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      SSTR2 [HSA:6752] [KO:K04218]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04024(6752)  cAMP signaling pathway
            hsa04080(6752)  Neuroactive ligand-receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Somatostatin
                SSTR2
                 D11845  Tidutamab (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11845  Tidutamab (USAN/INN)
DBLINKS     CAS: 2148354-90-7
///
